All lobbying filings

EMERGENT STRATEGIES

Lobbying for ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION · trade association representing the advanced medical technology industry

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $15,000.00 income · posted Oct 20, 2025

Official filing document

Bills named in this filing 1

S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Lobbying activity 5

Medical/Disease Research/Clinical Labs

Health tax issues and trade Issues related to Small Business Innovation Research Program PAHPA Reauthorization

Taxation/Internal Revenue Code

Issues relating to health tax issues and trade

Computer Industry

Issues related to health data privacy

Trade (domestic/foreign)

Issues related to CHIPS implementation and critical supply chains

Medicare/Medicaid

Issues on legislation pertaining to S.1717 Ensuring Patient Access to Critical Breakthrough Products Act of 2025 Issues related to transitional coverage of emerging technologies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.